Article
Dysregulation of the CD4+ T cells lineage differentiation in dyslipidemic patients and impact of lipoprotein-apheresis treatment: A case study.
Atherosclerosis. Supplements - 1 Nov 2017
Papin J, Brennand A, Arbore G, Hohenstein B, Kamvissi V, Kemper C, Bornstein S R
Abstract excerpt
BACKGROUND AND AIM: Lipoprotein-apheresis (LA) is a therapeutic approach used against severe forms of dyslipidemia in patients who are non-responders or intolerant to pharmacological treatments. However, little is known about the potential pleiotropic effects of LA, particularly regarding the immune system and its regulation. Thus, in an attempt to analyse the potential effects of dyslipidemia and LA on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
